PLUR Stock Analysis: Buy, Sell, or Hold?
$1.19
0.07 (6.25%)
▲
5d:
+32.22%
30d:
+22.67%
90d:
-24.68%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Nov 11, 2026
13d
Get Alerted When PLUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PLUR is 10.2% above its trading range ($1.08). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PLUR is 10.2% above its trading range ($1.08). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PLUR is currently trading at $1.19, which is considered extended relative to its 30-day fair value range of $0.94 to $1.08.
Technical Outlook: Technically, PLUR is in a strong downtrend. Immediate support is located at $0.85, while resistance sits at $1.36. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: PLUR scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+908.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PLUR is in a strong downtrend. Immediate support is located at $0.85, while resistance sits at $1.36. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: PLUR scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+908.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.94 -
$1.08
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+10.2% above its trading range)
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.2%)
- BULLISH: Trading 908.4% below Wall St target ($12.00)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.94 -
$1.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.85
Resistance Level
$1.36
Current Trend
Strong Downtrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$12.00
(+908.4%)
Revenue Growth (YoY)
-15.8%
Share & Embed Analysis
Last updated: October 28, 2026 5:29 AM ET
Data refreshes hourly during market hours. Next update: 6:29 AM
Data refreshes hourly during market hours. Next update: 6:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1144 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 47 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 64 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 54 HOLD |
|
CLYM
Climb Bio Inc |
STRONG BUY
16 analysts |
$28 | 51 HOLD |